z-logo
open-access-imgOpen Access
Zopiclone: A Third Generation of Hypnotics
Author(s) -
Anthony N. Nicholson
Publication year - 1983
Publication title -
pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.51
H-Index - 59
eISSN - 1423-0313
pISSN - 0031-7012
DOI - 10.1159/000137907
Subject(s) - zopiclone , anesthesia , medicine , psychology , hypnotic
Many years ago now the benzodiaze-pines began to replace the barbiturates, but, when we think about this change and remember that the barbiturates were probably being used in unnecessarily high doses, the therapeutic advantage of the benzodiaze-pines may not have been so great as it appeared at the time. The major advance was that of increased safety in overdosage. Initially, the benzodiazepines were used in relatively high doses, and so they may not have provided the most favourable balance possible between efficacy on one hand and adverse effects on the other. It has only been over the past few years that the advantage of lower doses of hypnotics has been widely appreciated, and this has been accompanied by the development of drugs with rapid rates of elimination. It is the rapidly eliminated hypnotics which we may now call the ‘Third Generation’; within this group there are several drugs, and their mean elimination half-lives differ. The different halflives may well have discrete clinical indications. They include the triazolodiazepines and the imidazodiaze-pines and a new chemical group – the cyclo-pyrolones – of which zopiclone (Imovane®), the subject of this symposium, is an example. Their advantage is that daily ingestion will not lead to accumulation. However, though a rapidly eliminated drug is unlikely to accumulate with appropriate daily dosage, it does not necessarily mean that its duration of action is short enough to avoid a residual effect. Many pharmacokinetic factors determine persistence of activity of an hypnotic, and these include the distribution phase which influences markedly the initial fall in plasma level. Nowadays, an hypnotic which has a favourable balance between efficacy on one hand and persistence of activity on the other, and which is without adverse effects on sleep either during administration or on withdrawal, is sought. In this context many of the currently available benzodiazepines when used appropriately have proved themselves in clinical practice, but there are certain aspects of their activity which have recently become 2 Nicholson

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom